Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason T Rich

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinomaPrashant Gabani, Alexander J Lin, Justin Barnes, et al.
Cancer Medicine|July 16, 2018
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of carePrashant Gabani, Justin Barnes, Alexander J Lin, et al.
Cancer Medicine|February 27, 2023
Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinomaEmily Z Yan, Benjamin M Wahle, Sean T Massa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 10, 2025
Unilateral vs Bilateral Transoral Robotic Surgery for HPV-Positive Tonsillar Squamous Cell CarcinomaAndrew M Peterson, Spencer R Bockover, Dorina Kallogjeri, et al.
JCO Precision Oncology|May 22, 2025
Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II TrialPeter J Oppelt, Jessica C Ley, Sidharth V Puram, et al.
Head & Neck|February 23, 2021
The prognostic significance of race in nasopharyngeal carcinoma by histological subtypeKatelyn O Stepan, Angela L Mazul, S Andrew Skillington, et al.
The Laryngoscope|September 17, 2016
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinomaJoseph Zenga, Ryan S Jackson, Evan M Graboyes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2020
Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survivalNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
American Journal of Otolaryngology|February 1, 2020
Tourniquet use and factors associated with hematoma formation in free tissue transferChristopher J Britt, Michelle S Hwang, Peter M Vila, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Radiation therapy dose de-escalation compared to standard dose radiation therapy in definitive treatment of HPV-positive oropharyngeal squamous cell carcinomaPrashant Gabani, Alexander J Lin, Justin Barnes, et al.
Cancer Medicine|July 16, 2018
Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of carePrashant Gabani, Justin Barnes, Alexander J Lin, et al.
Cancer Medicine|February 27, 2023
Race and socioeconomic status interact with HPV to influence survival disparities in oropharyngeal squamous cell carcinomaEmily Z Yan, Benjamin M Wahle, Sean T Massa, et al.
JAMA Otolaryngology-- Head & Neck Surgery|July 10, 2025
Unilateral vs Bilateral Transoral Robotic Surgery for HPV-Positive Tonsillar Squamous Cell CarcinomaAndrew M Peterson, Spencer R Bockover, Dorina Kallogjeri, et al.
JCO Precision Oncology|May 22, 2025
Palbociclib, a Selective CDK4/6 Inhibitor, Administered Before and After Chemoradiotherapy for Human Papillomavirus-Negative, Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm, Phase II TrialPeter J Oppelt, Jessica C Ley, Sidharth V Puram, et al.
Head & Neck|February 23, 2021
The prognostic significance of race in nasopharyngeal carcinoma by histological subtypeKatelyn O Stepan, Angela L Mazul, S Andrew Skillington, et al.
The Laryngoscope|September 17, 2016
Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinomaJoseph Zenga, Ryan S Jackson, Evan M Graboyes, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 23, 2015
Treatment Outcomes for T4 Oropharyngeal Squamous Cell CarcinomaJoseph Zenga, Michael Wilson, Douglas R Adkins, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 19, 2020
Regional lymph node irradiation in locally advanced Merkel cell carcinoma reduces regional and distant relapse and improves disease-specific survivalNeal Andruska, Lily Mahapatra, Randall J Brenneman, et al.
American Journal of Otolaryngology|February 1, 2020
Tourniquet use and factors associated with hematoma formation in free tissue transferChristopher J Britt, Michelle S Hwang, Peter M Vila, et al.
Pageof 8